Alessandro Orrù1,2, Lucia Caffino3, Federico Moro4, Chiara Cassina4, Giuseppe Giannotti3, Angelo Di Clemente4, Fabio Fumagalli3, Luigi Cervo5. 1. Experimental Psychopharmacology, Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via Giuseppe La Masa 19, 20156, Milan, Italy. alessandro.orru@ift.cnr.it. 2. Institute of Translational Pharmacology (C.N.R.), Parco Scientifico e Tecnologico della Sardegna, Polaris - Edificio 5 - Località, Piscinamanna, 09010, Pula, Cagliari, Italy. alessandro.orru@ift.cnr.it. 3. Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy. 4. Experimental Psychopharmacology, Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via Giuseppe La Masa 19, 20156, Milan, Italy. 5. Experimental Psychopharmacology, Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via Giuseppe La Masa 19, 20156, Milan, Italy. luigi.cervo@marionegri.it.
Abstract
RATIONALE: Although brain-derived neurotrophic factor (BDNF) is part of a homeostatic pathway involved in the development of alcohol dependence, it is not clear whether this is also true after recreational ethanol consumption. OBJECTIVES: We examined BDNF expression and signaling in the cortico-striatal network immediately and 24 h after either a single intravenous (i.v.) ethanol operant self-administration session or the last of 14 sessions. METHODS: To compare contingent and non-contingent ethanol exposure, we incorporated the "yoked control-operant paradigm" in which rats actively taking ethanol (S-Et) were paired with two yoked controls receiving passive infusions of ethanol (Y-Et) or saline. RESULTS: A single ethanol exposure transiently reduced BDNF mRNA levels in the medial prefrontal cortex (mPFC) of Y-Et. Immediately after the last of 14 sessions, mRNA and mature BDNF protein levels (mBDNF) were reduced in the mPFC in both S-Et and Y-Et while mBDNF expression was raised in the nucleus accumbens (NAc), suggesting enhanced anterograde transport from the mPFC. Conversely, 24 h later mBDNF expression and signaling were raised in the mPFC and NAc of S-Et rats but reduced in the NAc of Y-Et rats, with concomitant reduction of downstream signaling pathways. CONCLUSIONS: Our findings indicate that recreational-like i.v. doses of ethanol promote early changes in neurotrophin expression, depending on the length and modality of administration, the brain region investigated, and the presence of the drug. A rapid intervention targeting the BDNF system might be useful to prevent escalation to alcohol abuse.
RATIONALE: Although brain-derived neurotrophic factor (BDNF) is part of a homeostatic pathway involved in the development of alcohol dependence, it is not clear whether this is also true after recreational ethanol consumption. OBJECTIVES: We examined BDNF expression and signaling in the cortico-striatal network immediately and 24 h after either a single intravenous (i.v.) ethanol operant self-administration session or the last of 14 sessions. METHODS: To compare contingent and non-contingent ethanol exposure, we incorporated the "yoked control-operant paradigm" in which rats actively taking ethanol (S-Et) were paired with two yoked controls receiving passive infusions of ethanol (Y-Et) or saline. RESULTS: A single ethanol exposure transiently reduced BDNF mRNA levels in the medial prefrontal cortex (mPFC) of Y-Et. Immediately after the last of 14 sessions, mRNA and mature BDNF protein levels (mBDNF) were reduced in the mPFC in both S-Et and Y-Et while mBDNF expression was raised in the nucleus accumbens (NAc), suggesting enhanced anterograde transport from the mPFC. Conversely, 24 h later mBDNF expression and signaling were raised in the mPFC and NAc of S-Et rats but reduced in the NAc of Y-Et rats, with concomitant reduction of downstream signaling pathways. CONCLUSIONS: Our findings indicate that recreational-like i.v. doses of ethanol promote early changes in neurotrophin expression, depending on the length and modality of administration, the brain region investigated, and the presence of the drug. A rapid intervention targeting the BDNF system might be useful to prevent escalation to alcohol abuse.
Authors: Scott C Steffensen; Christine H Walton; David M Hansen; Jordan T Yorgason; Roger A Gallegos; Jose R Criado Journal: Pharmacol Biochem Behav Date: 2008-10-29 Impact factor: 3.533
Authors: Alex L Deal; Caroline E Bass; Valentina P Grinevich; Osvaldo Delbono; Keith D Bonin; Jeff L Weiner; Evgeny A Budygin Journal: Neuroscience Date: 2020-07-21 Impact factor: 3.590
Authors: Harold L Haun; William C Griffin; Marcelo F Lopez; Matthew G Solomon; Patrick J Mulholland; John J Woodward; Jacqueline F McGinty; Dorit Ron; Howard C Becker Journal: Neuropharmacology Date: 2018-07-26 Impact factor: 5.250
Authors: Mary H Patton; Katherine E Padgett; Paige N McKeon; Houman Qadir; Michael S Patton; Chaoqi Mu; Bradley M Roberts; Brian N Mathur Journal: Neuropsychopharmacology Date: 2019-02-13 Impact factor: 7.853
Authors: Jean R Geste; Brandon Levin; Isaac Wilks; Marjory Pompilus; Xiping Zhang; Karyn A Esser; Marcelo Febo; Laura O'Dell; Adriaan W Bruijnzeel Journal: Nicotine Tob Res Date: 2020-02-06 Impact factor: 4.244
Authors: Jeanelle Portelli; Mehdi Farokhnia; Sara L Deschaine; Jillian T Battista; Mary R Lee; Xiaobai Li; Dorit Ron; Lorenzo Leggio Journal: Alcohol Date: 2020-08-13 Impact factor: 2.405
Authors: Alexander Gómez-A; Carol A Dannenhoffer; Amanda Elton; Sung-Ho Lee; Woomi Ban; Yen-Yu Ian Shih; Charlotte A Boettiger; Donita L Robinson Journal: Front Pharmacol Date: 2021-11-29 Impact factor: 5.988